Rare diseases
Investigational molecules
Locations
Back to Denmark1 178 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis
DenmarkA Phase III Study of Once‑Weekly Petrelintide to Evaluate Efficacy and Safety for Weight Loss in Adults with Overweight or Obesity
DenmarkLong‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis
DenmarkGedatolisib with drug combination versus standard therapy as first‑line treatment for patients with advanced HR‑positive HER2‑negative breast cancer
DenmarkLong‑term safety of intrathecal VO659 in participants with Huntington’s disease, spinocerebellar ataxia type 1 or type 3
DenmarkStudy of Tozorakimab to Reduce Lung Inflammation and Promote Healing in Patients with COPD
DenmarkPhase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia
DenmarkMolecularly Tailored Therapy Versus Standard Care in Patients With Advanced Pancreatic Cancer Using Olaparib, Erlotinib, Crizotinib, Trametinib, Pemigatinib, Selpercatinib, Axitinib, Vismodegib, Pembrolizumab, Larotrectinib, Dabrafenib, Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan, Gemcitabine, Paclitaxel Albumin-Bound, and Calcium Folinate
DenmarkA study to evaluate the use of tocilizumab in adults with acute ischemic stroke undergoing mechanical clot removal.
DenmarkStudy of the effect of dapagliflozin on the development of post-transplant diabetes in kidney transplant recipients
DenmarkStudy of Human Normal Immunoglobulin in Adults with Secondary Immune Deficiency after CAR T‑cell or T‑cell Redirecting Therapy for Hematologic Malignancies
DenmarkA Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.
Ongoing investigations into personalized treatment approaches for various cancer types.
Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.
Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.
Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.
Advancing treatment options for patients with moderate to severe skin conditions.
Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.
Important research advancing preventive medicine and infection control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
